Oxybutynin Chloride Tablet
Product Images NDC 50090-4622

8 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-4622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Figure 1 Structure)

Structural Formula (Figure 1 Structure)
Chemical structure of oxybutynin chloride showing the molecular arrangement including aromatic rings, ester, and ethylamine groups with the hydrochloride salt indicated.*
FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
Data table presenting pharmacokinetic parameters of R-Oxybutynin and S-Oxybutynin, including maximum concentration (Cmax), time to maximum concentration (Tmax), and area under the curve values (AUCt and AUCinf), with units in ng/mL or hours as applicable.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

Figure 1 (Figure 3 Figure1)
A line graph depicting the mean plasma concentration of R-Oxybutynin over a 24-hour period following administration of Oxybutynin 5 mg TID. The x-axis represents time in hours, and the y-axis shows concentration in ng/mL, with error bars indicating variability at each time point.*
FDA Label Image

Table 2 (Figure 4 Table2)

Table 2 (Figure 4 Table2)
A data table presenting pharmacokinetic parameters including Cmax, Tmax, and AUC for four compounds: R-Oxybutynin, S-Oxybutynin, R-Desethyloxybutynin, and S-Desethyloxybutynin. Values are given as mean ± standard deviation, with notes explaining Cmax as peak concentration and AUC as area under the curve to end of dosing interval.*
FDA Label Image

Figure 2 (Figure 5 Figure2)

Figure 2 (Figure 5 Figure2)
A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) plotted against time (hours). The graph depicts concentration peaking between 0 and 2 hours and gradually declining to near baseline by 12 hours.*
FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
A data table listing adverse events reported with Oxybutynin Chloride use at doses of 5-20 mg per day among 199 subjects. It categorizes adverse events by body system, including Infections and Infestations, Psychiatric Disorders, Nervous System Disorders, Eye Disorders, Gastrointestinal Disorders, and Renal and Urinary Disorders, with corresponding percentages of incidence for each event.*
FDA Label Image
Kvk Logo (Figure 7 Company Logo)
FDA Label Image

Label Image (Lbl500904622)

Label Image (Lbl500904622)
Label for Oxybutynin Chloride 5 mg oral tablets by A-S Medication Solutions, NDC 50090-4622. The label includes storage instructions to keep at 68 to 77 degrees Fahrenheit and indicates a package quantity of 30 tablets. A QR code and lot number area are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.